SG48314A1 - Improved antibodies to plasmodium falciparum - Google Patents

Improved antibodies to plasmodium falciparum

Info

Publication number
SG48314A1
SG48314A1 SG1996008855A SG1996008855A SG48314A1 SG 48314 A1 SG48314 A1 SG 48314A1 SG 1996008855 A SG1996008855 A SG 1996008855A SG 1996008855 A SG1996008855 A SG 1996008855A SG 48314 A1 SG48314 A1 SG 48314A1
Authority
SG
Singapore
Prior art keywords
plasmodium falciparum
improved antibodies
antibodies
improved
falciparum
Prior art date
Application number
SG1996008855A
Other languages
English (en)
Inventor
Hahn Gerald Dewayne
Hans H Feindt
Melissa S Maret
Keith Uithoven
Original Assignee
Becton Dickinson Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Becton Dickinson Co filed Critical Becton Dickinson Co
Publication of SG48314A1 publication Critical patent/SG48314A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/20Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
    • C07K16/205Plasmodium
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445Plasmodium
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
SG1996008855A 1992-09-11 1993-08-27 Improved antibodies to plasmodium falciparum SG48314A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US94528792A 1992-09-11 1992-09-11

Publications (1)

Publication Number Publication Date
SG48314A1 true SG48314A1 (en) 1998-04-17

Family

ID=25482919

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996008855A SG48314A1 (en) 1992-09-11 1993-08-27 Improved antibodies to plasmodium falciparum

Country Status (10)

Country Link
US (3) US5478741A (cs)
EP (1) EP0588122B1 (cs)
JP (1) JP2537589B2 (cs)
AU (2) AU670108B2 (cs)
CA (1) CA2104899C (cs)
DE (1) DE69321914T2 (cs)
ES (1) ES2124276T3 (cs)
MY (1) MY109957A (cs)
SG (1) SG48314A1 (cs)
TW (1) TW258738B (cs)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9403819D0 (en) * 1994-02-28 1994-04-20 Univ Leeds Control of parasites
GB9505447D0 (en) * 1995-03-17 1995-05-03 Common Services Agency Competitive binding assay
US20030036106A1 (en) * 1996-10-28 2003-02-20 Burke Thomas J. Kinase and phosphatase activity measurement using fluorescence polarization
EP0980431A1 (en) * 1997-05-14 2000-02-23 Human Genome Sciences, Inc. Antimicrobial peptide
US20020102620A1 (en) * 1999-05-07 2002-08-01 S. Melissa Maret Antibodies and peptides for detection of plasmodium vivax
AU762944B2 (en) 1999-06-23 2003-07-10 Cornell Research Foundation Inc. Dehydration/rehydration of marked liposomes on a test device
US6576460B1 (en) 1999-10-28 2003-06-10 Cornell Research Foundation, Inc. Filtration-detection device and method of use
EP1939627B1 (en) 2002-05-31 2010-08-18 Cornell Research Foundation, Inc. Methods to detect analytes in samples
AU2003270619A1 (en) 2002-09-12 2004-04-30 Molecular Probes, Inc. Site-specific labeling of affinity tags in fusion proteins
FR2865541B1 (fr) * 2003-05-20 2006-08-11 Commissariat Energie Atomique Procede de detection de fluorure ou de fluorure d'hydrogene et trousse de detection
DK1718967T3 (da) * 2004-02-03 2013-06-03 Diadexus Inc Metoder til at detektere Lp-PLA2 aktivitet
KR101035111B1 (ko) * 2004-06-30 2011-05-19 주식회사 엘지생명과학 말라리아 플라스모듐 팔시파룸의 면역학적 측정방법 및이에 사용되는 측정 수단
JP4599928B2 (ja) * 2004-08-02 2010-12-15 東洋紡績株式会社 ペプチドの固定化方法
JP4508765B2 (ja) * 2004-08-02 2010-07-21 東洋紡績株式会社 ペプチドの固定化方法
US9568471B2 (en) * 2005-01-25 2017-02-14 The Johns Hopkins University Plasmodium diagnostic assay device
EP2239573A3 (en) * 2005-03-30 2011-02-08 Saladax Biomedical Inc. Doxorubicin derivatives and conjugates for doxorubicin immunoassay
US20070072242A1 (en) * 2005-09-22 2007-03-29 Randox Laboratories Limited Immunoassay method and kit to leucomalachite green and malachite green
EP2623610B1 (en) * 2006-02-10 2015-04-29 Life Technologies Corporation Labeling and detection of post translationally modified proteins
WO2007137418A1 (en) * 2006-05-27 2007-12-06 Winnik Mitchell A Polymer backbone element tags
CA2659251C (en) 2006-07-10 2016-06-14 The Regents Of The University Of California Luminescent 1-hydroxy-2-pyridinone chelates of lanthanides
PT2047270E (pt) * 2006-07-28 2013-10-17 Beckman Coulter Inc Agentes de estabilização e ligandos de captura para utilização em ensaios de medição de concentrações de analito
JP5420414B2 (ja) 2006-10-06 2014-02-19 シリゲン グループ リミテッド 指向性バイオマーカシグナル増幅用の蛍光方法および材料
TWI368905B (en) 2006-11-17 2012-07-21 Princeton Technology Corp Circuits for generating radio frequency zero cross signal of optical disc drive
US9239329B2 (en) * 2006-12-18 2016-01-19 Japan Science And Technology Agency Method of measuring interaction between biomaterial and sugar chain, method of evaluating biomaterial in sugar chain selectivity, method of screening biomaterial, method of patterning biomaterials, and kits for performing these methods
FR2914066B1 (fr) * 2007-03-20 2009-05-22 Polyintell Sarl Kit d'analyse comprenant au moins deux polymeres a empreintes moleculaires et au moins un marqueur, ainsi que le procede d'analyse l'utilisant
US8320230B2 (en) 2007-05-17 2012-11-27 Mediatek Inc. Processing circuits and methods for optical data
US7943370B2 (en) * 2007-08-23 2011-05-17 Canon Kabushiki Kaisha Structure, target substance detection element and target substance detection kit
US8556843B2 (en) * 2008-02-02 2013-10-15 AccelDx Blood purification method and apparatus for the treatment of malaria
WO2010051544A2 (en) * 2008-10-31 2010-05-06 Lumiphore, Inc. Rapid homogeneous diagnostic testing platform based on lanthanide fluorescent resonance energy transfer
EP2816038B8 (en) 2009-08-24 2019-12-25 Lumiphore, Inc. Hopo chelators
US20110189088A1 (en) * 2009-12-24 2011-08-04 Lumiphore, Inc. Radiopharmaceutical complexes
AP2012006517A0 (en) * 2010-03-23 2012-10-31 Univ Michigan State Histidine rich protein-2 diagnostic test for cerebral malaria
CN103221424A (zh) * 2010-09-03 2013-07-24 俄勒冈健康科学大学 具有共价结合肽的重组t细胞受体配体
US11453652B2 (en) 2013-03-15 2022-09-27 Lumiphore, Inc. Di-macrocycles
SG10201906981TA (en) * 2013-12-03 2019-09-27 Harvard College Methods and reagents for the assessment of gestational diabetes
GB201409516D0 (en) * 2014-05-29 2014-07-16 Randox Lab Ltd Immunoassay for compounds of the NBOMe family
EP3761036A1 (en) * 2015-03-03 2021-01-06 ARK Diagnostics, Inc. Pregabalin immunoassays
EP3288912A4 (en) * 2015-05-01 2018-11-07 Biolegend, Inc. Stable nanomagnetic particle dispersions
JP6963570B2 (ja) * 2016-02-26 2021-11-10 アジレント・テクノロジーズ・インクAgilent Technologies, Inc. 求核剤の標識を向上するためのビスピリジンの使用
WO2017174610A1 (en) * 2016-04-05 2017-10-12 Universite De Strasbourg Intra-droplet surface engineering to capture a molecular target
WO2017190117A1 (en) 2016-04-30 2017-11-02 BioLegend, Inc. Compositions and methods for performing magnetibuoyant separations
WO2018195008A1 (en) 2017-04-21 2018-10-25 Mellitus, Llc Methods and antibodies for diabetes-related applications
CA3097002A1 (en) * 2018-04-13 2019-10-17 Fluidigm Canada Inc. Stabilized cell acquisition for elemental analysis
CN111378035B (zh) * 2018-12-29 2021-10-08 东莞市朋志生物科技有限公司 抗恶性疟原虫hrp-ii重组抗体
CN111378034B (zh) * 2018-12-29 2021-10-12 东莞市朋志生物科技有限公司 抗恶性疟原虫hrp-ii抗体
CN114605533B (zh) * 2020-12-08 2023-02-28 东莞市朋志生物科技有限公司 抗恶性疟原虫hrp-ii的抗体、检测恶性疟原虫的试剂和试剂盒
US20220214350A1 (en) * 2021-01-05 2022-07-07 Encodia, Inc. Methods for stable complex formation and related kits

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE388694B (sv) 1975-01-27 1976-10-11 Kabi Ab Sett att pavisa ett antigen exv i prov av kroppvetskor, med utnyttjande av till porost berarmaterial bundna eller adsorberande antikroppar
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
US4666866A (en) 1983-04-19 1987-05-19 Krauth Gary H Immunoassay for antigens employing supported binder
US4493795A (en) * 1983-10-17 1985-01-15 Syntex (U.S.A.) Inc. Synthetic peptide sequences useful in biological and pharmaceutical applications and methods of manufacture
US4703017C1 (en) 1984-02-14 2001-12-04 Becton Dickinson Co Solid phase assay with visual readout
US4695554A (en) 1984-02-14 1987-09-22 Becton Dickinson And Company Sac or liposome containing dye (sulforhodamine) for immunoassay
US4743560A (en) 1984-03-26 1988-05-10 Becton Dickinson And Company Solid phase assay
US4632901A (en) 1984-05-11 1986-12-30 Hybritech Incorporated Method and apparatus for immunoassays
GB2169901A (en) 1984-12-11 1986-07-23 Lkb Biochrom Ltd method for a solid phase synthesis of a linear combination of amino acid residues.
AU5603786A (en) * 1985-04-11 1986-10-16 Walter And Eliza Hall Institute Of Medical Research, The Highly repetitive antigens - sharp-arp-mesa-plasmodium falciparum
IL78476A0 (en) * 1985-04-11 1986-08-31 Inst Medical W & E Hall Highly repetitive antigens of plasmodium falciparum
US5130416A (en) * 1986-08-13 1992-07-14 The United States Of America As Represented By The Department Of Health And Human Services Recombinant DNA clone containing a genomic fragment of PfHRP-II gene from plasmodium falciparum
US5030558A (en) 1986-11-07 1991-07-09 Syntex (U.S.A.) Inc. Qualitative immunochromatographic method and device
US5001225A (en) * 1986-12-08 1991-03-19 Georgetown University Monoclonal antibodies to a pan-malarial antigen
US4920046A (en) 1987-02-20 1990-04-24 Becton, Dickinson And Company Process, test device, and test kit for a rapid assay having a visible readout
US4855240A (en) 1987-05-13 1989-08-08 Becton Dickinson And Company Solid phase assay employing capillary flow
WO1989001785A1 (en) 1987-09-04 1989-03-09 Georgetown University Monoclonal antibodies to a plasmodium falciparum protein
DE3737238A1 (de) * 1987-11-03 1989-05-18 Behringwerke Ag Rekombinantes histidinreiches protein (37 kd antigen) von plasmodium falciparum, seine herstellung und verwendung
US4818677A (en) 1987-12-03 1989-04-04 Monoclonal Antibodies, Inc. Membrane assay using focused sample application
US5096837A (en) 1990-02-08 1992-03-17 Pacific Biotech, Inc. Immunochromatographic assay and method of using same
EP0474891A1 (en) * 1990-09-08 1992-03-18 BEHRINGWERKE Aktiengesellschaft Vectors for expression of malarial antigens on the surface of Salmonella vaccine strains
JP2002054521A (ja) 2000-08-11 2002-02-20 Honda Motor Co Ltd エンジンの燃料ポンプ取付構造

Also Published As

Publication number Publication date
CA2104899A1 (en) 1994-03-12
US5478741A (en) 1995-12-26
JP2537589B2 (ja) 1996-09-25
US5604117A (en) 1997-02-18
TW258738B (cs) 1995-10-01
JPH06225789A (ja) 1994-08-16
AU670108B2 (en) 1996-07-04
AU683000B2 (en) 1997-10-23
CA2104899C (en) 2000-10-17
DE69321914D1 (de) 1998-12-10
AU4487293A (en) 1994-03-17
EP0588122A1 (en) 1994-03-23
ES2124276T3 (es) 1999-02-01
AU6449996A (en) 1996-12-12
MY109957A (en) 1997-10-31
DE69321914T2 (de) 1999-03-25
EP0588122B1 (en) 1998-11-04
US5665552A (en) 1997-09-09

Similar Documents

Publication Publication Date Title
SG48314A1 (en) Improved antibodies to plasmodium falciparum
AU115930S (en) Brooch
GB2269639B (en) One-way synchronizer
EP0567918A3 (en) Azopigment preparation
GB2176191B (en) Antigens of plasmodium falciparum
GB2272770B (en) Improvements to electrocardiagraphs
ZA911950B (en) Plasmodium sporozoite antigen
AU2384688A (en) Monoclonal antibodies to a plasmodium falciparum protein
EP0217877A4 (en) VERY REPEATABLE ANTIGENS FROM PLASMODIUM FALCIPARUM.
GB8905857D0 (en) Plasmodium merozoite rhoptries antigen
ZA947564B (en) Production of antigens
GB9102294D0 (en) Antigen of plasmodium falciparum
ZA888983B (en) Rhoptry antigen of plasmodium falciparum
ZA913829B (en) Modified acrylic capstock
EP0553954A3 (en) Preparation of tetramethyldiamino-polyoxyethylenes
ZA856960B (en) Antigens of plasmodium falciparum
GB9214043D0 (en) Improvements relating to sachets
GB9202491D0 (en) Parasite antigens
ZA862732B (en) Highly repetitive antigens of plasmodium falciparum
EP0516721A4 (en) Antigenic proteins of plasmodium
GB9211317D0 (en) Novel antigens
GB9207360D0 (en) Antigen preparation
BG96312A (en) Antiacidic preparation
GB9115147D0 (en) Method of bonding
ZA939163B (en) Sustained-release preparation